A comparative review of neutrophil extracellular traps in sepsis

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Sepsis is the leading cause of critical illness and mortality in human beings and animals. Neutrophils are the primary effector cells of innate immunity during sepsis. Besides degranulation and phagocytosis, neutrophils also release neutrophil extracellular traps (NETs), composed of cell-free DNA, histones, and antimicrobial proteins. Although NETs have protective roles in the initial stages of sepsis, excessive NET formation has been found to induce thrombosis and multiple organ failure in murine sepsis models. Since the discovery of NETs nearly a decade ago, many investigators have identified NETs in various species. However, many questions remain regarding the exact mechanisms and fate of neutrophils following NET formation. In humans and mice, platelet-neutrophil interactions via direct binding or soluble mediators seem to play an important role in mediating NET formation during sepsis. Preliminary data suggest that these interactions may be species dependent. Regardless of these differences, there is increasing evidence in human and veterinary medicine suggesting that NETs play a crucial role in the pathogenesis of intravascular thrombosis and multiple organ failure in sepsis. Because the outcome of sepsis is highly dependent on early recognition and intervention, detection of NETs or NET components can aid in the diagnosis of sepsis in humans and veterinary species. In addition, the use of novel therapies such as deoxyribonuclease and non-anticoagulant heparin to target NET components shows promising results in murine septic models. Much work is needed in translating these NET-targeting therapies to clinical practice.

Original languageEnglish (US)
Article number291
JournalFrontiers in Veterinary Science
Volume5
Issue numberNOV
DOIs
StatePublished - Nov 28 2018

Fingerprint

neutrophils
Sepsis
traps
Neutrophils
Multiple Organ Failure
Extracellular Traps
thrombosis
Thrombosis
mice
Veterinary Medicine
Deoxyribonucleases
antimicrobial proteins
Phagocytosis
Innate Immunity
Critical Illness
Histones
deoxyribonucleases
therapeutics
Heparin
heparin

Keywords

  • Acute respiratory distress syndrome
  • Citrullinated histones
  • Immunothrombosis
  • Platelet-neutrophil interaction
  • Veterinary critical care

ASJC Scopus subject areas

  • veterinary(all)

Cite this

A comparative review of neutrophil extracellular traps in sepsis. / Li, Ronald H L; Tablin, Fern.

In: Frontiers in Veterinary Science, Vol. 5, No. NOV, 291, 28.11.2018.

Research output: Contribution to journalReview article

@article{a51ecf69fe72493c8ef65442eeadb4e3,
title = "A comparative review of neutrophil extracellular traps in sepsis",
abstract = "Sepsis is the leading cause of critical illness and mortality in human beings and animals. Neutrophils are the primary effector cells of innate immunity during sepsis. Besides degranulation and phagocytosis, neutrophils also release neutrophil extracellular traps (NETs), composed of cell-free DNA, histones, and antimicrobial proteins. Although NETs have protective roles in the initial stages of sepsis, excessive NET formation has been found to induce thrombosis and multiple organ failure in murine sepsis models. Since the discovery of NETs nearly a decade ago, many investigators have identified NETs in various species. However, many questions remain regarding the exact mechanisms and fate of neutrophils following NET formation. In humans and mice, platelet-neutrophil interactions via direct binding or soluble mediators seem to play an important role in mediating NET formation during sepsis. Preliminary data suggest that these interactions may be species dependent. Regardless of these differences, there is increasing evidence in human and veterinary medicine suggesting that NETs play a crucial role in the pathogenesis of intravascular thrombosis and multiple organ failure in sepsis. Because the outcome of sepsis is highly dependent on early recognition and intervention, detection of NETs or NET components can aid in the diagnosis of sepsis in humans and veterinary species. In addition, the use of novel therapies such as deoxyribonuclease and non-anticoagulant heparin to target NET components shows promising results in murine septic models. Much work is needed in translating these NET-targeting therapies to clinical practice.",
keywords = "Acute respiratory distress syndrome, Citrullinated histones, Immunothrombosis, Platelet-neutrophil interaction, Veterinary critical care",
author = "Li, {Ronald H L} and Fern Tablin",
year = "2018",
month = "11",
day = "28",
doi = "10.3389/fvets.2018.00291",
language = "English (US)",
volume = "5",
journal = "Frontiers in Veterinary Science",
issn = "2297-1769",
publisher = "Frontiers Media S. A.",
number = "NOV",

}

TY - JOUR

T1 - A comparative review of neutrophil extracellular traps in sepsis

AU - Li, Ronald H L

AU - Tablin, Fern

PY - 2018/11/28

Y1 - 2018/11/28

N2 - Sepsis is the leading cause of critical illness and mortality in human beings and animals. Neutrophils are the primary effector cells of innate immunity during sepsis. Besides degranulation and phagocytosis, neutrophils also release neutrophil extracellular traps (NETs), composed of cell-free DNA, histones, and antimicrobial proteins. Although NETs have protective roles in the initial stages of sepsis, excessive NET formation has been found to induce thrombosis and multiple organ failure in murine sepsis models. Since the discovery of NETs nearly a decade ago, many investigators have identified NETs in various species. However, many questions remain regarding the exact mechanisms and fate of neutrophils following NET formation. In humans and mice, platelet-neutrophil interactions via direct binding or soluble mediators seem to play an important role in mediating NET formation during sepsis. Preliminary data suggest that these interactions may be species dependent. Regardless of these differences, there is increasing evidence in human and veterinary medicine suggesting that NETs play a crucial role in the pathogenesis of intravascular thrombosis and multiple organ failure in sepsis. Because the outcome of sepsis is highly dependent on early recognition and intervention, detection of NETs or NET components can aid in the diagnosis of sepsis in humans and veterinary species. In addition, the use of novel therapies such as deoxyribonuclease and non-anticoagulant heparin to target NET components shows promising results in murine septic models. Much work is needed in translating these NET-targeting therapies to clinical practice.

AB - Sepsis is the leading cause of critical illness and mortality in human beings and animals. Neutrophils are the primary effector cells of innate immunity during sepsis. Besides degranulation and phagocytosis, neutrophils also release neutrophil extracellular traps (NETs), composed of cell-free DNA, histones, and antimicrobial proteins. Although NETs have protective roles in the initial stages of sepsis, excessive NET formation has been found to induce thrombosis and multiple organ failure in murine sepsis models. Since the discovery of NETs nearly a decade ago, many investigators have identified NETs in various species. However, many questions remain regarding the exact mechanisms and fate of neutrophils following NET formation. In humans and mice, platelet-neutrophil interactions via direct binding or soluble mediators seem to play an important role in mediating NET formation during sepsis. Preliminary data suggest that these interactions may be species dependent. Regardless of these differences, there is increasing evidence in human and veterinary medicine suggesting that NETs play a crucial role in the pathogenesis of intravascular thrombosis and multiple organ failure in sepsis. Because the outcome of sepsis is highly dependent on early recognition and intervention, detection of NETs or NET components can aid in the diagnosis of sepsis in humans and veterinary species. In addition, the use of novel therapies such as deoxyribonuclease and non-anticoagulant heparin to target NET components shows promising results in murine septic models. Much work is needed in translating these NET-targeting therapies to clinical practice.

KW - Acute respiratory distress syndrome

KW - Citrullinated histones

KW - Immunothrombosis

KW - Platelet-neutrophil interaction

KW - Veterinary critical care

UR - http://www.scopus.com/inward/record.url?scp=85057479208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057479208&partnerID=8YFLogxK

U2 - 10.3389/fvets.2018.00291

DO - 10.3389/fvets.2018.00291

M3 - Review article

AN - SCOPUS:85057479208

VL - 5

JO - Frontiers in Veterinary Science

JF - Frontiers in Veterinary Science

SN - 2297-1769

IS - NOV

M1 - 291

ER -